Anti-tumor effects of depleting and non-depleting anti-CD27 monoclonal antibodies in immune-competent mice

Biochemical and Biophysical Research Communications

Volumn 393, Issue 4, 2010, Pages 829-835

  Sakanishi, Tamami ^a   Yagita, Hideo ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antibody therapy; CD27; Cytotoxic T lymphocytes; T cell co stimulation

Indexed keywords

CD27 MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; RM 273E5; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; DRUG MECHANISM; IMMUNOCOMPETENCE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL LYMPHOMA;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD27; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; LYMPHOMA, T-CELL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC;

MUS; MUS MUSCULUS;

EID: 77949485107     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.02.092     Document Type: Article

References (23)

1. Cheson B.D., and Leonard J.P. Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma. N. Engl. J. Med. 359 (2008) 613-626
2. Tedder T.F., Baras A., and Xiu Y. Fcgamma receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity. Springer Semin. Immunopathol. 28 (2006) 351-364
3. Melero I., Hervas-Stubbs S., Glennie M., Pardoll D.M., and Chen L. Immunostimulatory monoclonal antibodies for cancer therapy. Nat. Rev. Cancer 7 (2007) 95-106
4. Watts T.H. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23 (2005) 23-68
5. French R.R., Chan H.T., Tutt A.L., and Glennie M.J. CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help. Nat. Med. 5 (1999) 548-553
6. + T cells. J. Immunol. 174 (2005) 710-717
7. Taraban V.Y., Rowley T.F., and Al-Shamkhani A. Cutting edge: a critical role for CD70 in CD8 T cell priming by CD40-licensed APCs. J. Immunol. 173 (2004) 6542-6546
8. Hendriks J., Xiao Y., and Borst J. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J. Exp. Med. 198 (2003) 1369-1380
9. Hendriks J., Gravestein L.A., Tesselaar K., van Lier R.A., Schumacher T.N., and Borst J. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1 (2000) 433-440
10. Ranheim E.A., Cantwell M.J., and Kipps T.J. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells. Blood 85 (1995) 3556-3565
11. van Oers M.H., Pals S.T., Evers L.M., van der Schoot C.E., Koopman G., Bonfrer J.M., Hintzen R.Q., von dem Borne A.E., and van Lier R.A. Expression and release of CD27 in human B-cell malignancies. Blood 82 (1993) 3430-3436
12. Oshima H., Nakano H., Nohara C., Kobata T., Nakajima A., Jenkins N.A., Gilbert D.J., Copeland N.G., Muto T., Yagita H., and Okumura K. Characterization of murine CD70 by molecular cloning and mAb. Int. Immunol. 10 (1998) 517-526
13. Takeda K., Oshima H., Hayakawa Y., Akiba H., Atsuta M., Kobata T., Kobayashi K., Ito M., Yagita H., and Okumura K. CD27-mediated activation of murine NK cells. J. Immunol. 164 (2000) 1741-1745
14. Gravestein L.A., Blom B., Nolten L.A., de Vries E., van der Horst G., Ossendorp F., Borst J., and Loenen W.A. Cloning and expression of murine CD27: comparison with 4-1BB, another lymphocyte-specific member of the nerve growth factor receptor family. Eur. J. Immunol. 23 (1993) 943-950
15. Melero I., Shuford W.W., Newby S.A., Aruffo A., Ledbetter J.A., Hellstrom K.E., Mittler R.S., and Chen L. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat. Med. 3 (1997) 682-685
16. Hamaguchi Y., Xiu Y., Komura K., Nimmerjahn F., and Tedder T.F. Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy. J. Exp. Med. 203 (2006) 743-753
17. Cartron G., Dacheux L., Salles G., Solal-Celigny P., Bardos P., Colombat P., and Watier H. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. Blood 99 (2002) 754-758
18. Niwa R., Hatanaka S., Shoji-Hosaka E., Sakurada M., Kobayashi Y., Uehara A., Yokoi H., Nakamura K., and Shitara K. Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 is independent of FcgammaRIIIa functional polymorphism. Clin. Cancer Res. 10 (2004) 6248-6255
19. Prasad K.V., Ao Z., Yoon Y., Wu M.X., Rizk M., Jacquot S., and Schlossman S.F. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc. Natl. Acad. Sci. USA 94 (1997) 6346-6351
20. Suntharalingam G., Perry M.R., Ward S., Brett S.J., Castello-Cortes A., Brunner M.D., and Panoskaltsis N. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med. 355 (2006) 1018-1028
21. Hixon J.A., Blazar B.R., Anver M.R., Wiltrout R.H., and Murphy W.J. Antibodies to CD40 induce a lethal cytokine cascade after syngeneic bone marrow transplantation. Biol. Blood Marrow Transplant. 7 (2001) 136-143
22. Niu L., Strahotin S., Hewes B., Zhang B., Zhang Y., Archer D., Spencer T., Dillehay D., Kwon B., Chen L., Vella A.T., and Mittler R.S. Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice. J. Immunol. 178 (2007) 4194-4213
23. Zhu Y., Zhu G., Luo L., Flies A.S., and Chen L. CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype. Blood 109 (2007) 4882-4889